BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 8157953)

  • 1. Control of the rat T cell response to retroviral and bacterial superantigens by class II MHC products and Tcrb-V8.2 alleles.
    Herrmann T; Hochgrebe T; Torres-Nagel NE; Huber BT; Hünig T
    J Immunol; 1994 May; 152(9):4300-9. PubMed ID: 8157953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alleles of highly homologous rat T cell receptor beta-chain variable segments 8.2 and 8.4: strain-specific expression, reactivity to superantigens, and binding of the mAb R78.
    Asmuss A; Hofmann K; Hochgrebe T; Giegerich G; Hünig T; Herrmann T
    J Immunol; 1996 Nov; 157(10):4436-41. PubMed ID: 8906819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thymic repertoire selection by superantigens: presentation by human and mouse MHC molecules.
    Simpson E; Takacs K; Altmann DM
    Thymus; 1994; 23(1):1-13. PubMed ID: 7863543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Presentation of the Mls-1 superantigen by human HLA class II molecules to murine T cells.
    Subramanyam M; McLellan B; Labrecque N; Sekaly RP; Huber BT
    J Immunol; 1993 Sep; 151(5):2538-45. PubMed ID: 8395548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T cell receptor V beta repertoire in mice lacking endogenous mouse mammary tumor provirus.
    Braun MY; Jouvin-Marche E; Marche PN; MacDonald HR; Acha-Orbea H
    Eur J Immunol; 1995 Mar; 25(3):857-62. PubMed ID: 7705418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intercellular adhesion molecule-1 and leukocyte function-associated antigen-3 provide costimulation for superantigen-induced T lymphocyte proliferation in the absence of a specific presenting molecule.
    Lamphear JG; Stevens KR; Rich RR
    J Immunol; 1998 Jan; 160(2):615-23. PubMed ID: 9551895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered orientation of streptococcal superantigen (SSA) on HLA-DR1 allows unconventional regions to contribute to SSA Vbeta specificity.
    Stevens KR; Van M; Lamphear JG; Rich RR
    J Immunol; 1996 Dec; 157(11):4970-8. PubMed ID: 8943403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MHC-specific recognition of a bacterial superantigen by weakly reactive T cells.
    Surman S; Deckhut AM; Blackman MA; Woodland DL
    J Immunol; 1994 May; 152(10):4893-902. PubMed ID: 8176210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The expression of CD4 and CD8 molecules conditions the behavior of V beta + murine thymocytes upon superantigenic challenge.
    Fattorossi A; Baschieri S; Ferlini C; Doria G
    Thymus; 1997; 24(3):133-45. PubMed ID: 9151379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Requirement of class II and membrane proximal region of mouse mammary tumor virus superantigen (Mtv SAG) in Mtv7 SAG presentation].
    Okamoto M; Kimura S; Katagiri M
    Hokkaido Igaku Zasshi; 1998 May; 73(3):205-14. PubMed ID: 9719947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacterial proteins that mediate the association of a defined subset of T cell receptor:CD4 complexes with class II MHC.
    Yagi J; Baron J; Buxser S; Janeway CA
    J Immunol; 1990 Feb; 144(3):892-901. PubMed ID: 2136903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A V beta 4-specific superantigen encoded by a new exogenous mouse mammary tumor virus.
    Maillard I; Erny K; Acha-Orbea H; Diggelmann H
    Eur J Immunol; 1996 May; 26(5):1000-6. PubMed ID: 8647159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contrasting contributions of complementarity-determining region 2 and hypervariable region 4 of rat BV8S2+ (Vbeta8.2) TCR to the recognition of myelin basic protein and different types of bacterial superantigens.
    Kreiss M; Asmuss A; Krejci K; Lindemann D; Miyoshi-Akiyama T; Uchiyama T; Rink L; Broeren CP; Herrmann T
    Int Immunol; 2004 May; 16(5):655-63. PubMed ID: 15096488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The J alpha segment contributes to the affinity of V beta 6+ cells for vSAG-7 (Mls-1a) presented by I-A molecules.
    Churaqui E; Oukka M; Tilloy F; Mayadoux E; Bruley-Rosset M; Kosmatopoulos K
    Immunology; 1995 Apr; 84(4):609-18. PubMed ID: 7790035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of superantigen-induced T cell activation in the absence and the presence of MHC class II.
    Lando PA; Olsson C; Kalland T; Newton D; Kotb M; Dohlsten M
    J Immunol; 1996 Oct; 157(7):2857-63. PubMed ID: 8816390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vbeta-restricted T cell adherence to endothelial cells: a mechanism for superantigen-dependent vascular injury.
    Brogan PA; Shah V; Klein N; Dillon MJ
    Arthritis Rheum; 2004 Feb; 50(2):589-97. PubMed ID: 14872503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dramatic hyperplasia of mtv-2+ lymph node grafts in mtv-2- recipients and selective stimulation of V beta 14+ T cells in recipients' lymph nodes in the DDD mouse.
    Matsuzawa A; Nakano H; Sakamoto S; Yoshimoto T; Nariuchi H
    J Immunol; 1995 Feb; 154(4):1644-52. PubMed ID: 7836749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variable influence of MHC polymorphism on the recognition of bacterial superantigens by T cells.
    Wen R; Blackman MA; Woodland DL
    J Immunol; 1995 Aug; 155(4):1884-92. PubMed ID: 7636239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitation of endogenous mouse mammary tumor virus superantigen expression by lymphocyte subsets.
    Waanders GA; Lees RK; Held W; MacDonald HR
    Eur J Immunol; 1995 Sep; 25(9):2632-7. PubMed ID: 7589137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Superantigen-like properties of an antibody bispecific for MHC class II molecules and the V beta domain of the T cell antigen receptor.
    Yagi J; Nakata M; Uchiyama T; Nishikawa M; Mizushima Y; Nishioka K; Ito K; Yagita H; Okumura K; Janeway CA
    J Immunol; 1994 Apr; 152(8):3833-41. PubMed ID: 8144952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.